$12.56 +0.28 (%) Horizon Pharma PLC - NASDAQ

Oct. 1, 2014 | 04:00 PM

Partner Headlines

  1. Horizon Pharma Offers Update on Effectiveness of S-4 Registration

    Benzinga | Aug. 8, 2014 | 07:32AM EST
  2. Morning Market Movers

    Benzinga | Aug. 7, 2014 | 09:44AM EST
  3. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 7, 2014 | 08:08AM EST
  4. Stocks Lower As Earnings Season Takes Back Seat To Geopolitical Uncertainties

    Benzinga | Jul. 29, 2014 | 16:37PM EST
  5. Morning Market Losers

    Benzinga | Jul. 29, 2014 | 09:54AM EST
  6. Markets Little Changed Ahead Of The Federal Reserve's Policy Decision

    Benzinga | Jul. 28, 2014 | 16:36PM EST
  7. Horizon Pharma Drugs Ditched By Pharmacies; Stock Falls

    IBD | Jul. 28, 2014 | 11:14AM EST
  8. Morning Market Losers

    Benzinga | Jul. 28, 2014 | 09:48AM EST
  9. Benzinga's Top #PreMarket Losers

    Benzinga | Jul. 28, 2014 | 08:19AM EST
  10. Horizon guides '14 sales up

    IBD | May. 9, 2014 | 19:25PM EST
  11. Horizon Pharma Q1 Beats Street; Guidance Mixed

    IBD | May. 9, 2014 | 11:12AM EST
  12. Benzinga's Top #PreMarket Gainers

    Benzinga | May. 9, 2014 | 08:14AM EST
  13. Earnings Scheduled For May 9, 2014

    Benzinga | May. 9, 2014 | 05:18AM EST
  14. Horizon Pharma Reports Inducement Grants

    Benzinga | Apr. 23, 2014 | 16:36PM EST
  15. Horizon Pharma Announces Early Termination of Hart-Scott-Rodino Waiting Period for Acquisition of Vidara Therapeutics International Ltd

    Benzinga | Apr. 16, 2014 | 07:31AM EST
  16. Mid-Afternoon Market Update: Markets Go Red as Anadarko Rallies on Settlement with US

    Benzinga | Apr. 3, 2014 | 15:45PM EST
  17. Mid-Day Market Update: US Stocks Fall; Google Shares Rise After Stock Split

    Benzinga | Apr. 3, 2014 | 12:41PM EST
  18. Horizon Buys Ireland's Vidara

    IBD | Mar. 19, 2014 | 18:45PM EST
  19. Benzinga's M&A Chatter for Wednesday March 19, 2014

    Benzinga | Mar. 19, 2014 | 17:54PM EST
  20. Mid-Afternoon Market Update: Markets Drop Sharply During Janet Yellen's First Conference

    Benzinga | Mar. 19, 2014 | 16:19PM EST
  21. Afternoon Movers for Wednesday, March 19th 2014

    Benzinga | Mar. 19, 2014 | 15:54PM EST
  22. Mid-Day Market Update: Oracle Shares Decline On Weak Results; Horizon Pharma Jumps

    Benzinga | Mar. 19, 2014 | 12:04PM EST
  23. Top Trending Tickers On StockTwits For March 19

    Benzinga | Mar. 19, 2014 | 10:52AM EST
  24. Horizon Pharma To Buy Vidara, Join Exodus To Ireland

    IBD | Mar. 19, 2014 | 10:45AM EST
  25. Horizon Inks $660M Reverse Merger With Ireland's Vidara

    FoxBusiness | Mar. 19, 2014 | 10:30AM EST
  26. Mid-Morning Market Update: Markets Edge Higher; FedEx Profit Misses Estimates

    Benzinga | Mar. 19, 2014 | 10:12AM EST
  27. Stocks Hitting 52-Week Highs

    Benzinga | Mar. 19, 2014 | 10:12AM EST
  28. Morning Market Movers

    Benzinga | Mar. 19, 2014 | 09:36AM EST
  29. Benzinga's Top #PreMarket Gainers

    Benzinga | Mar. 19, 2014 | 08:07AM EST
  30. UPDATE: Horizon Pharma Announces the Purchase of Vidara Therapeutics for $660M in Stock, Cash

    Benzinga | Mar. 19, 2014 | 07:13AM EST
  31. EARLIER: Horizon Pharma Announces the Purchase of Vidara Therapeutics for $660M in Stock, Cash

    Benzinga | Mar. 19, 2014 | 07:13AM EST
  32. Horizon Pharma Banks On Two-For-One Arthritis Drugs

    IBD | Mar. 14, 2014 | 14:05PM EST
  33. Morning Market Losers

    Benzinga | Mar. 13, 2014 | 09:50AM EST
  34. Benzinga's Top #PreMarket Losers

    Benzinga | Mar. 13, 2014 | 08:15AM EST
  35. Earnings Scheduled For March 13, 2014

    Benzinga | Mar. 13, 2014 | 04:51AM EST
  36. Will Horizon Pharma Spike Again On Quarterly Report?

    IBD | Mar. 12, 2014 | 08:02AM EST
  37. Horizon Pharma Names Robert F. Carey Executive Vice President and Chief Business Officer

    Benzinga | Mar. 5, 2014 | 07:30AM EST
  38. Horizon Pharma Issues Update on Feb. 10-11th FDA Joint Panel Meeting on CV Risk of NSAIDs

    Benzinga | Feb. 11, 2014 | 16:43PM EST
  39. Stocks Hitting 52-Week Highs

    Benzinga | Nov. 19, 2013 | 10:55AM EST
  40. Benzinga's Top #PreMarket Gainers

    Benzinga | Nov. 19, 2013 | 08:16AM EST
  41. Horizon Pharma Announces Pricing of $150M of 5.00% Convertible Senior Notes

    Benzinga | Nov. 19, 2013 | 07:13AM EST
  42. Horizon to Acquire US Rights for VIMOVO from Pozen

    Benzinga | Nov. 19, 2013 | 06:18AM EST
  43. Benzinga's Top #PreMarket Gainers

    Benzinga | Nov. 8, 2013 | 08:08AM EST
  44. Benzinga's Top Pre-Market Gainers

    Benzinga | Oct. 21, 2013 | 08:10AM EST
  45. Horizon Pharma Reports Clinical Data on RAYOS Tablets Which Will Be Presented at American College of Rheumatology Annual Meeting

    Benzinga | Oct. 21, 2013 | 07:35AM EST
  46. Benzinga's Top Upgrades

    Benzinga | Oct. 21, 2013 | 07:32AM EST
  47. Horizon Pharma Reports Sanofi Compiegne as Added Manufacturing Site for DUEXIS

    Benzinga | Sep. 5, 2013 | 07:34AM EST
  48. Horizon Pharma Reports Settlement of DUEXIS Patent Litigation with Par Pharma

    Benzinga | Aug. 22, 2013 | 07:39AM EST
  49. Horizon Pharma Inc (HZNP) President, Chairman and CEO Timothy P Walbert sells 20,749 Shares

    GuruFocus | Jan. 3, 2013 | 09:07AM EST
  50. Horizon Pharma Inc (HZNP) EVP & CFO Vaere Robert J De sells 20,544 Shares

    GuruFocus | Jan. 3, 2013 | 09:07AM EST
Trading Center